ArticlePloS one2025
Life-time experience of violence among women and girls living with disability in Nepal.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundViolence against women and girls with disabilities remains a serious, yet underexplored, global concern. This paper aims to investigate the prevalence and factors associated with life-time experience of violence within this vulnerable population in Nepal.
methodsThis cross-sectional study was conducted in 28 municipalities representing all seven provinces as well as all three ecological regions of Nepal. A total of 1,294 women and girls with disability aged 15-59 years participated in this study. Data were collected in the period August to October 2021. This was done by trained enumerators using the KoBo application on smartphones or tablets. Both written and oral informed consent was sought from all participants. Each participant was assured of utmost confidentiality and privacy. Cross-tabulations were performed in STATA 18 to determine the distribution of the prevalence of violence. Also, bivariable and multivariable logistic regression models were fitted to establish association between the participants' characteristics and odds of experiencing violence.
resultsOverall, 457 (35.32%) women living with disabilities had ever experienced violence at a point in their lifetime. Psychological/emotional violence was the most prevalent violence (74.40%) followed by physical violence (31.07%) and denial of services (28.67%). Age was positively associated with the likelihood of experiencing violence. Women belonging to the Brahman/Chhetri ethnic group had reduced odds of violence [AOR = 0.56; 95%CI: 0.37-0.85] compared to Hill Dalits. Divorced or separated women showed a markedly higher likelihood of experiencing violence [AOR = 6.69; 95%CI: 2.31-19.40] compared to currently married women. Participants who had not witnessed violence against other women exhibited significantly higher odds of experiencing violence [AOR = 1.86; 95%CI: 1.20-2.89]. Women living in the Koshi province [AOR = 4.04; 95%CI: 2.54-6.42], Madhesh province [AOR = 2.16; 95%CI: 1.15-4.08] and Bagmati province [AOR = 2.21; 95%CI: 1.41-3.46] reported significantly higher odds of experiencing violence compared to those in Karnali.
conclusionThe study concludes that age, ethnicity, marital status, and provincial residence are significant predictors of violence among women living with disability in Nepal. Interventions aimed at addressing violence against women living with disability in Nepal must prioritize older women and those who were previously married. Also, priority must be given to Koshi, Madhesh and Bagmati provinces where the prevalence and risk of experiencing violence is highest.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.